The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids
Abstract
Corticosteroids mediate a variety of immunological actions and are commonly utilized in the treatment of a wide range of diseases. Unfortunately, therapy with this class of medications is associated with a large proportion of non-responders and significant side effects. Inhaled corticosteroids are the most commonly used asthma controller therapy. However, asthmatic response to corticosteroids also varies widely between individuals. We investigated the genetic contribution to the variation in response to inhaled corticosteroid therapy in asthma. The association of longitudinal change in lung function and single nucleotide polymorphisms from candidate genes crucial to the biologic actions of corticosteroids were evaluated in three independent asthmatic clinical trial populations utilizing inhaled corticosteroids as the primary therapy in at least one treatment arm. Variation in one gene, corticotropin-releasing hormone receptor 1 (CRHR1) was consistently associated with enhanced response to therapy in each of our three populations. Individuals homozygous for the variants of interest manifested a doubling to quadrupling of the lung function response to corticosteroids compared with lack of the variants (P-values ranging from 0.006 to 0.025 for our three asthmatic populations). As the primary receptor mediating the release of adrenocorticotropic hormone, which regulates endogenous cortisol levels, CRHR1 plays a pivotal, pleiotropic role in steroid biology. These data indicate that genetic variants in CRHR1 have pharmacogenetic effects influencing asthmatic response to corticosteroids, provide a rationale for predicting therapeutic response in asthma and other corticosteroid-treated diseases, and suggests this gene pathway as a potential novel therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Statistical Method for Haplotype Reconstruction from Population Data
Stephens, M., Smith, N. J., & Donnelly, P. (2001) · The American Journal of Human Genetics · doi:10.1086/319501 · Cited by 7,493
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
Long-Term Effects of Budesonide or Nedocromil in Children with Asthma
(2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431501 · Cited by 1,365
Haplotype tagging for the identification of common disease genes
Johnson, G. C. L., Esposito, L., Barratt, B. J., Smith, A. N., Heward, J., Di Genova, G., Ueda, H., Cordell, H. J., Eaves, I. A., Dudbridge, F., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-233 · Cited by 1,174 · cited 1×
“Owing to linkage disequilibrium (LD) and/or limited haplotype diversity, haplotypes may be distinguished using a subset of SNPs, termed ‘haplotype-tag SNPs’ (htSNPs) (9).”
BackgroundSignificant variability in response to inhaled corticosteroids for persistent asthma
Szefler, S. J., Martin, R. J., King, T. S., Boushey, H. A., Cherniack, R. M., Chinchilli, V. M., Craig, T. J., Dolovich, M., Drazen, J. M., Fagan, J. K., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122635 · Cited by 622
Self-citationMalmstrom, K., Rodriguez-Gomez, G., Guerra, J., Villaran, C., Piñeiro, A., Wei, L. X., Seidenberg, B. C., Reiss, T. F., & for the Montelukast/Beclomethasone Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00005 · Cited by 617
The CRF peptide family and their receptors: yet more partners discovered
Dautzenberg, F. M., & Hauger, R. L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01946-6 · Cited by 532
Theoharides, T. C., Singh, L. K., Boucher, W. S., Pang, X., Létourneau, R., Webster, E., & Chrousos, G. P. (1998) · Endocrinology · doi:10.1210/en.139.1.403 · Cited by 447
Habib, K. E., Weld, K. P., Rice, K. C., Pushkas, J., Champoux, M., Listwak, S., Webster, E. L., Atkinson, A. J., Schulkin, J., Contoreggi, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.6079 · Cited by 403
Third International Pediatric Consensus statement on the management of childhood asthma
Warner, J. O., Naspitz, C. K., & Cropp, G. J. A. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199801)25:1<1::aid-ppul1>3.0.co;2-s · Cited by 389
The Childhood Asthma Management Program (CAMP)
(1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00044-0 · Cited by 352
A Comparison of Budesonide and Mesalamine for Active Crohn's Disease
Thomsen, O. Ø., Cortot, A., Jewell, D., Wright, J. P., Winter, T., Veloso, F. T., Vatn, M., Persson, T., & Pettersson, E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390603 · Cited by 327
Heterogeneity of therapeutic responses in asthma
Drazen, J. M., Silverman, E. K., & Lee, T. H. (2000) · British Medical Bulletin · doi:10.1258/0007142001903535 · Cited by 318
Self-citationELENKOV, I. J., WEBSTER, E. L., TORPY, D. J., & CHROUSOS, G. P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07618.x · Cited by 247
Pisarchik, A., & Slominski, A. T. (2001) · The FASEB Journal · doi:10.1096/fj.01-0487fje · Cited by 187
A Comparison of Budesonide and Mesalamine for Active Crohn's Disease
(2001) · New England Journal of Medicine · doi:10.1056/nejm200111293452221 · Cited by 178
Sebastiani, P., Lazarus, R., Weiss, S. T., Kunkel, L. M., Kohane, I. S., & Ramoni, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633613100 · Cited by 174
Self-citationMolecular biology of the CRH receptors— in the mood
Dautzenberg, F. M., Kilpatrick, G. J., Hauger, R. L., & Moreau, J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00388-6 · Cited by 131
A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS
Sun, X. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.e68 · Cited by 99
Liaw, C. W., Grigoriadis, D. E., Lovenberg, T. W., Souza, E. B. D., & Maki, R. A. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.7.9946 · Cited by 85
Presentation of new GINA guidelines for paediatrics
Mutius, V. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00089.x · Cited by 66
Xu, G., Rabadan‐Diehl, C., Nikodémová, M., WYNN, P. C., Spiess, J., & Aguilera, G. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.3.485 · Cited by 46
Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo
Drolet, G., & Rivest, S. (2001) · Peptides · doi:10.1016/s0196-9781(01)00389-8 · Cited by 44
The genomic organization of the human corticotropin-releasing factor type-1 receptor
Sakai, K., Yamada, M., HORIBA, N., Wakui, M., Demura, H., & Suda, T. (1998) · Gene · doi:10.1016/s0378-1119(98)00322-9 · Cited by 43
Funada, M., Hara, C., & Wada, K. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01402-9 · Cited by 35
Cited by
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
Gyamfi-Bannerman, C., Thom, E. A., Blackwell, S. C., Tita, A. T. N., Reddy, U. M., Saade, G. R., Rouse, D. J., McKenna, D. S., Clark, E. A. S., Thorp, J. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516783 · Cited by 814
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
Clinical Pharmacology of Corticosteroids
Williams, D. M. (2018) · Respiratory Care · doi:10.4187/respcare.06314 · Cited by 460
“General recommendations regarding the need to consider a tapering regimen are (1) prednisone 30 mg daily (or equivalent) for at least 2 weeks, (2) any dose of any systemic corticosteroid for at least 1 month, or (3) when signs and symptoms of hypothalamic-pituitary-adrenal axis suppression are already present.”
BackgroundKey role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Fanta, C. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804579 · Cited by 400
Metadata
- Authors
- Tantisira, K. G., Lake, S., Silverman, E. S., Palmer, L. J., Lazarus, R., Silverman, E. K., Liggett, S. B., Gelfand, E. W., Rosenwasser, L. J., Richter, B., Israel, E., Wechsler, M., Gabriel, S., Altshuler, D., Lander, E., Drazen, J., & Weiss, S. T.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-05
- Volume
- 13
- Issue
- 13
- Pages
- 1353-1359
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2108449402
- Cited by
- 322
- References
- 27
- FWCI
- 11.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.